Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00004892
What this trial is testing

O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT01526837
What this trial is testing

Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence

Who this might be right for
Glioblastoma Multiforme
Brain & Spine Surgeons of New York 1
Large-scale testing (Phase 3)UnknownNCT01759810
What this trial is testing

Proteome-based Personalized Immunotherapy of Glioblastoma

Who this might be right for
Glioblastoma
NeuroVita Clinic 60
Testing effectiveness (Phase 2)Study completedNCT00003478
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 10
Testing effectiveness (Phase 2)Study completedNCT00085540
What this trial is testing

FR901228 in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT01257594
What this trial is testing

EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas

Who this might be right for
Brain Cancer
Andrew B Lassman, MD 22
Early research (Phase 1)Study completedNCT03020602
What this trial is testing

BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab

Who this might be right for
GliosarcomaRecurrent GlioblastomaAstrocytoma of Brain+1 more
Seema Nagpal 12
Testing effectiveness (Phase 2)UnknownNCT04552977
What this trial is testing

A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Shandong Cancer Hospital and Institute 50
Not applicableStudy completedNCT02507102
What this trial is testing

A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia

Who this might be right for
Glioblastoma Multiforme
Nativis, Inc. 11
Testing effectiveness (Phase 2)Study completedNCT02330991
What this trial is testing

A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse

Who this might be right for
Glioblastoma
Beijing Sanbo Brain Hospital 204
Early research (Phase 1)Looking for participantsNCT06815432
What this trial is testing

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
Baylor College of Medicine 27
Testing effectiveness (Phase 2)Study completedNCT01478178
What this trial is testing

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma

Who this might be right for
GliomaGlioblastomaGlioblastoma Multiforme+2 more
Kintara Therapeutics, Inc. 55
Testing effectiveness (Phase 2)Study completedNCT00672243
What this trial is testing

Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme

Who this might be right for
GlioblastomaGliosarcoma
Duke University 32
Testing effectiveness (Phase 2)UnknownNCT00005084
What this trial is testing

Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04145115
What this trial is testing

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

Who this might be right for
Astrocytoma, IDH-Mutant, Grade 4Diffuse GliomaGlioblastoma, IDH-Wildtype+1 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT01967810
What this trial is testing

ANG1005 in Patients With Recurrent High-Grade Glioma

Who this might be right for
GliomaGlioblastomaBrain Tumor, Recurrent
Angiochem Inc 73
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT01048008
What this trial is testing

Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer

Who this might be right for
Advanced CancerBrain Involvement
DEKK-TEC, Inc. 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT02981940
What this trial is testing

Abemaciclib in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Dana-Farber Cancer Institute 45
Early research (Phase 1)Study completedNCT00036972
What this trial is testing

Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Next Page